Quality assessment | No. of patients | Treatment effect (95% CI) | Quality of the evidence | |||||||
---|---|---|---|---|---|---|---|---|---|---|
No. of studies | Design | Limitations | Inconsistency | Indirectness | Imprecision | Other considerations | OMT | Untreated | ||
Pain (measured with: Pain VAS from 0 to 100 [worse pain]; Better indicated by lower values) | ||||||||||
2 | randomised trials | no serious limitations | no serious inconsistency | no serious indirectness | serious1 | none | 60 | 59 | MD 41.85 lower (49.43 to 34.27 lower) | ⊕ ⊕ ⊕Ο MODERATE |
Functional status (measured with: Oswestry Pain Questionnaire; Better indicated by lower values) | ||||||||||
2 | randomised trials | no serious limitations | no serious inconsistency | no serious indirectness | serious1 | none | 60 | 59 | SMD 1.78 lower (2.21 to 1.35 lower) | ⊕ ⊕ ⊕Ο MODERATE |